Sierra Oncology, Inc. Recorded Big Gain

Wed, Apr 13, 2022 at 05:30 PM

Sierra Oncology, Inc. (SRRA:NASDAQ) soared at $54.75, representing a gain of 38.5%. On Tue, Apr 12, 2022, SRRA:NASDAQ hit a New 2-Week High of $39.52. The stock appeared on our News Catalysts scanner on Wed, Apr 13, 2022 at 02:06 PM in the 'ACQUISITION' category. From Tue, Mar 29, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days

About Sierra Oncology, Inc. (SRRA:NASDAQ)

Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.

Top 10 Gainers:

Kaleido Biosciences, Inc. (KLDO:NASDAQ), 75.06%
Antares Pharma, Inc. (ATRS:NASDAQ), 49.2%
Veru Inc. (VERU:NASDAQ), 42.86%
Sierra Oncology, Inc. (SRRA:NASDAQ), 38.54%
Biofrontera Inc. (BFRI:NASDAQ), 34.05%
Creatd Inc. (CRTD:NASDAQ), 33.14%
HighPeak Energy Inc. (HPK:NASDAQ), 31.76%
Planet Green Holdings Corp. (PLAG:NYSEMKT), 26.8%
Turning Point Therapeutics, Inc. (TPTX:NASDAQ), 25.13%
Hallador Energy Company (HNRG:NASDAQ), 25.06%